| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 5 | +20.00% | -9.87% | -1.29% | -8.57% | -16.95% | — |
| 14d | 5 | +80.00% | +6.92% | -0.47% | +7.39% | +7.70% | — |
| 30d | 5 | +100.00% | +3.68% | -0.91% | +4.59% | +0.50% | — |
| 60d | 5 | +20.00% | -0.26% | +0.43% | -0.69% | -4.94% | — |
| 90d | 5 | +80.00% | +1.57% | +0.99% | +0.58% | +27.32% | — |
| 180d | 5 | +0.00% | -52.09% | +8.88% | -63.40% | -63.40% | — |
| 1y | 5(3 pending) | +0.00% | -61.43% | +20.40% | -81.83% | -81.83% | — |
| 2y | 5(3 pending) | +0.00% | -40.07% | +24.41% | -64.48% | -64.48% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| OVID OVID THERAPEUTICS INC. | SALE Executive Chairman | 47,333 | — | — | 0 | Mar 23, 2026 | Mar 25, 2026 ↗ | View → |
| OVID OVID THERAPEUTICS INC. | PURCHASE Executive Chairman | 47,333 | $1.40 | $66.3K | 3,735,048 | Mar 23, 2026 | Mar 25, 2026 ↗ | View → |
| OVID OVID THERAPEUTICS INC. | PURCHASEGRANT Stock grant | 957,000 | — | — | 957,000 | Feb 26, 2026 | Mar 2, 2026 ↗ | View → |
| OVID OVID THERAPEUTICS INC. | PURCHASE CEO | 71,000 | — | — | 3,687,715 | Dec 15, 2025 | Dec 18, 2025 ↗ | View → |
| OVID OVID THERAPEUTICS INC. | SALE CEO | 71 | — | — | 0 | Dec 15, 2025 | Dec 18, 2025 ↗ | View → |
| OVID OVID THERAPEUTICS INC. | PURCHASE CEO | 35,500 | — | — | 35,500 | Dec 11, 2025 | Dec 18, 2025 ↗ | View → |
| OVID OVID THERAPEUTICS INC. | PURCHASE CEO | 71 | — | — | 71 | Dec 11, 2025 | Dec 18, 2025 ↗ | View → |
| OVID OVID THERAPEUTICS INC. | PURCHASE CEO | 47,333 | — | — | 47,333 | Dec 11, 2025 | Dec 18, 2025 ↗ | View → |
| OVID OVID THERAPEUTICS INC. | PURCHASEGRANT Stock grant | 1,650,000 | — | — | 1,650,000 | Feb 20, 2025 | Feb 24, 2025 ↗ | View → |
| OVID OVID THERAPEUTICS INC. | PURCHASE CEO | 18,248 | $2.76 | $50.4K | 3,616,715 | Mar 18, 2024 | Mar 20, 2024 ↗ | View → |
| OVID OVID THERAPEUTICS INC. | PURCHASEGRANT Stock grant | 700,000 | — | — | 700,000 | Feb 22, 2024 | Feb 26, 2024 ↗ | View → |
| OVID OVID THERAPEUTICS INC. | SALEGRANT Gift | 573,275 | — | — | 4,171,742 | Dec 4, 2023 | Dec 6, 2023 ↗ | View → |
| OVID OVID THERAPEUTICS INC. | SALEGRANT Gift | 573,275 | — | — | 3,598,467 | Dec 4, 2023 | Dec 6, 2023 ↗ | View → |
| OVID OVID THERAPEUTICS INC. | PURCHASEGRANT Stock grant | 600,000 | — | — | 600,000 | Feb 23, 2023 | Feb 27, 2023 ↗ | View → |
| OVID OVID THERAPEUTICS INC. | PURCHASEGRANT Stock grant | 423,244 | — | — | 423,244 | Apr 8, 2022 | Apr 12, 2022 ↗ | View → |
| OVID OVID THERAPEUTICS INC. | PURCHASEGRANT Stock grant | 600,000 | — | — | 600,000 | Feb 3, 2022 | Feb 4, 2022 ↗ | View → |
| OVID OVID THERAPEUTICS INC. | PURCHASEGRANT Stock grant | 650,000 | — | — | 650,000 | Dec 17, 2020 | Dec 21, 2020 ↗ | View → |
| OVID OVID THERAPEUTICS INC. | PURCHASE CEO | 8,488 | $5.84 | $49.6K | 5,792,530 | Aug 28, 2020 | Sep 1, 2020 ↗ | View → |
| OVID OVID THERAPEUTICS INC. | SALEGRANT Gift | 465,116 | — | — | 0 | Sep 20, 2019 | Feb 14, 2024 ↗ | View → |